MedTrace Logo

Efficacy of Corticoid Infiltration in Quadratus Lumborum Syndrome

NCT03407027 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2018-01-23

No results posted yet for this study

Summary

This study has the primary goal of evaluating the efficacy of corticoid infiltration in the quadratus lumborum syndrome, aiming to determine if there are benefits with the use of corticosteroids and if they exist, if this improvement comes only from the systemic effects of corticosteroid administration.

Conditions

  • Low Back Pain

Interventions

DRUG

Quadratus triamcinolone

40mg of triamcinolone and 10ml of levobupivacaine 0,25%.

DRUG

Gluteus triamcinolone

40mg of triamcinolone and 10ml of levobupivacaine 0,25%.

DRUG

quadratus without triamcinolone.

10ml of levobupivacaine 0,25%.

Sponsors & Collaborators

  • University of Minho

    collaborator OTHER

  • Hospital de Braga

    lead OTHER

Principal Investigators

  • Ana Cunha, MD · Hospital of Braga, Braga, Minho, Portugal, 4710-243

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2019-04-30
Completion
2019-11-01

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03407027 on ClinicalTrials.gov